Hot Paths

U.S. tariffs on Singapore-based pharma companies postponed – report (EWS:NYSEARCA)

Singapore skyline of financial district with modern office buildings and Merlion Park as seen from Esplanade.

mkitina4/iStock Editorial via Getty Images

The implementation of the U.S. 100% tariff on Singapore’s pharmaceutical exports—originally scheduled to take effect October 1, 2025—has been delayed to allow pharmaceutical companies time to negotiate possible exemptions with the U.S. administration, The Straits Times reported.

The postponed

Exit mobile version